Advertisement
Organisation › Details
Advalytix AG
Advalytix AG (Munich) was founded in 2000 and has been a wholly owned subsidiary of Olympus Life and Material Science Europa GmbH since 2005. Within the Olympus Group, Advalytix is the world wide centre of expertise for cell-based molecular diagnostics. One of the company's main focuses is the miniaturisation of diagnostic and biological tests for research and development.
Advalytix products uniquely link imaging technologies such as microscopy with nucleic acid analysis, enabling Advalytix to offer turnkey system solutions consisting of both instruments and reagents. Advalytix has developed a portfolio of products for these applications, based on proprietary microelectronics technologies, such as surface acoustic waves (SAW).
*
Start | 2000-11-03 splitoff | |
End | 2005-04-04 renamed data ca. | |
Group | Danaher (Group) | |
Today | Beckman Coulter Biomedical GmbH (Advalytix) | |
Predecessor | LMU Munich, Center for Nanoscience | |
Successor | Olympus Life Science Research Europa GmbH (Advalytix) | |
Industry | lab-on-a-chip technology | |
Region | München (Munich) | |
Country | Germany | |
Street | 50 Sauerbruchstr. | |
City | 81377 München | |
Tel | +49-89-579589-3540 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Danaher (Group)
- [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
- [2] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
- [3] faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim....
- [4] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
- [5] Cevec Pharmaceuticals GmbH. (7/27/21). "Press Release: Cevec Closes Growth Financing Round to Serve Strong Demand in Viral Vector Technologies for Cell and Gene Therapies". Cologne....
- [6] Biognosys AG. (6/15/21). "Press Release: Biognosys Announces New Release of Spectronaut". Schlieren....
- [7] Cytiva. (6/2/21). "Press Release: Cytiva Acquires GoSilico to Strengthen Digital Capabilities in Bioprocessing"....
- [8] Lunaphore Technologies S.A.. (5/13/21). "Press Release: Lunaphore Announces Appointment of Matthias Weber, former President of Leica Biosystems, to Board of Directors". Lausanne....
- [9] Leica Microsystems AG. (3/16/21). "Press Release: Leica Microsystems Acquires Aivia, a Leading AI-enabled 3D Microscopy, Image Visualization and Analysis Software Solution". Wetzlar....
- [10] Cevec Pharmaceuticals GmbH. (2/2/21). "Press Release: Cevec and Carisma Therapeutics Sign License Agreement for the Use of CAP Technology in Anti-tumor Cell Therapies". Cologne & Philadelphia, PA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top